For most of his childhood, Connor Dalby could not walk without help. His life was shaped by seizures, developmental problems and constant medical care. Then an experimental custom drug changed what his family thought was possible. The treatment was designed around Connor's specific genetic mutation. It did not simply treat symptoms. It targeted the faulty copy of a gene involved in his epilepsy. Within months, his seizures had fallen by 90%. He also began taking steps without assistance for the first time. His story is now raising a bigger question about medicine: what if some drugs could be designed for one patient at a time?